Cargando…
Synthetic lethality of drug-induced polyploidy and BCL-2 inhibition in lymphoma
Spontaneous whole genome duplication and the adaptive mutations that disrupt genome integrity checkpoints are infrequent events in B cell lymphomas. This suggests that lymphomas might be vulnerable to therapeutics that acutely trigger genomic instability and polyploidy. Here, we report a therapeutic...
Autores principales: | Portelinha, Ana, da Silva Ferreira, Mariana, Erazo, Tatiana, Jiang, Man, Asgari, Zahra, de Stanchina, Elisa, Younes, Anas, Wendel, Hans-Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024740/ https://www.ncbi.nlm.nih.gov/pubmed/36934096 http://dx.doi.org/10.1038/s41467-023-37216-2 |
Ejemplares similares
-
NOXA genetic amplification or pharmacologic induction primes lymphoma cells to BCL2 inhibitor-induced cell death
por: Liu, Yuxuan, et al.
Publicado: (2018) -
ASN007 is a selective ERK1/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors
por: Portelinha, Ana, et al.
Publicado: (2021) -
Synthetic Polyploidy in Grafted Crops
por: Ruiz, Marta, et al.
Publicado: (2020) -
Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma
por: Mondello, Patrizia, et al.
Publicado: (2017) -
TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma
por: Erazo, Tatiana, et al.
Publicado: (2022)